NBT Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Sell |
7,879
-44
| -0.6% | -$6.16K | 0.07% | 200 |
|
|
2025
Q4 | $972K | Sell |
7,923
-48
| -0.6% | -$5.83K | 0.06% | 211 |
|
|
2025
Q3 | $885K | Sell |
7,971
-886
| -10% | -$101K | 0.06% | 217 |
|
|
2025
Q2 | $982K | Sell |
8,857
-132
| -1% | -$14K | 0.07% | 208 |
|
|
2025
Q1 | $1.01M | Sell |
8,989
-277
| -3% | -$28.6K | 0.07% | 206 |
|
|
2024
Q4 | $856K | Sell |
9,266
-379
| -4% | -$34.1K | 0.06% | 223 |
|
|
2024
Q3 | $809K | Sell |
9,645
-80
| -0.8% | -$6.1K | 0.05% | 235 |
|
|
2024
Q2 | $667K | Sell |
9,725
-241
| -2% | -$16.1K | 0.05% | 248 |
|
|
2024
Q1 | $730K | Sell |
9,966
-330
| -3% | -$25.4K | 0.05% | 232 |
|
|
2023
Q4 | $834K | Hold |
10,296
| – | – | 0.07% | 215 |
|
|
2023
Q3 | $772K | Buy |
10,296
+3,883
| +61% | +$299K | 0.07% | 186 |
|
|
2023
Q2 | $494K | Buy |
6,413
+346
| +6% | +$27.6K | 0.07% | 177 |
|
|
2023
Q1 | $503K | Hold |
6,067
| – | – | 0.07% | 170 |
|
|
2022
Q4 | $521K | Sell |
6,067
-183
| -3% | -$14.5K | 0.08% | 171 |
|
|
2022
Q3 | $386K | Sell |
6,250
-3,417
| -35% | -$215K | 0.06% | 179 |
|
|
2022
Q2 | $597K | Sell |
9,667
-1
| -0% | -$62 | 0.09% | 150 |
|
|
2022
Q1 | $575K | Sell |
9,668
-542
| -5% | -$34.6K | 0.08% | 153 |
|
|
2021
Q4 | $742K | Sell |
10,210
-40
| -0.4% | -$2.75K | 0.1% | 145 |
|
|
2021
Q3 | $716K | Hold |
10,250
| – | – | 0.1% | 145 |
|
|
2021
Q2 | $705K | Sell |
10,250
-60
| -0.6% | -$4.01K | 0.1% | 145 |
|
|
2021
Q1 | $667K | Buy |
10,310
+550
| +6% | +$35.5K | 0.1% | 145 |
|
|
2020
Q4 | $569K | Buy |
9,760
+1,019
| +12% | +$61.5K | 0.09% | 149 |
|
|
2020
Q3 | $553K | Sell |
8,741
-90
| -1% | -$6.24K | 0.09% | 151 |
|
|
2020
Q2 | $680K | Buy |
8,831
+265
| +3% | +$20.3K | 0.12% | 136 |
|
|
2020
Q1 | $640K | Buy |
8,566
+550
| +7% | +$38K | 0.13% | 131 |
|
|
2019
Q4 | $521K | Buy |
8,016
+2,710
| +51% | +$176K | 0.08% | 156 |
|
|
2019
Q3 | $336K | Buy |
5,306
+699
| +15% | +$45.7K | 0.06% | 167 |
|
|
2019
Q2 | $311K | Sell |
4,607
-100
| -2% | -$6.58K | 0.06% | 164 |
|
|
2019
Q1 | $306K | Sell |
4,707
-493
| -9% | -$32.8K | 0.06% | 158 |
|
|
2018
Q4 | $325K | Sell |
5,200
-1,037
| -17% | -$72.5K | 0.05% | 162 |
|
|
2018
Q3 | $482K | Sell |
6,237
-2,636
| -30% | -$199K | 0.08% | 149 |
|
|
2018
Q2 | $629K | Sell |
8,873
-9,548
| -52% | -$674K | 0.11% | 136 |
|
|
2018
Q1 | $1.39M | Sell |
18,421
-1,988
| -10% | -$158K | 0.23% | 99 |
|
|
2017
Q4 | $1.46M | Sell |
20,409
-18,757
| -48% | -$1.42M | 0.23% | 101 |
|
|
2017
Q3 | $3.17M | Buy |
39,166
+4,274
| +12% | +$327K | 0.51% | 65 |
|
|
2017
Q2 | $2.47M | Sell |
34,892
-6,380
| -15% | -$425K | 0.4% | 73 |
|
|
2017
Q1 | $2.8M | Buy |
41,272
+27,685
| +204% | +$1.95M | 0.47% | 68 |
|
|
2016
Q4 | $973K | Buy |
13,587
+88
| +0.7% | +$6.54K | 0.17% | 116 |
|
|
2016
Q3 | $1.07M | Sell |
13,499
-1,365
| -9% | -$111K | 0.19% | 112 |
|
|
2016
Q2 | $1.24M | Buy |
14,864
+1,208
| +9% | +$107K | 0.22% | 103 |
|
|
2016
Q1 | $1.25M | Buy |
13,656
+429
| +3% | +$38.7K | 0.22% | 104 |
|
|
2015
Q4 | $1.34M | Sell |
13,227
-519
| -4% | -$54K | 0.24% | 102 |
|
|
2015
Q3 | $1.35M | Sell |
13,746
-205
| -1% | -$22.8K | 0.25% | 100 |
|
|
2015
Q2 | $1.63M | Sell |
13,951
-639
| -4% | -$69.8K | 0.27% | 99 |
|
|
2015
Q1 | $1.43M | Sell |
14,590
-200
| -1% | -$20.3K | 0.23% | 106 |
|
|
2014
Q4 | $1.39M | Buy |
14,790
+150
| +1% | +$15.5K | 0.22% | 105 |
|
|
2014
Q3 | $1.56M | Sell |
14,640
-500
| -3% | -$49K | 0.25% | 102 |
|
|
2014
Q2 | $1.26M | Buy |
15,140
+485
| +3% | +$37.8K | 0.19% | 111 |
|
|
2014
Q1 | $1.04M | Sell |
14,655
-1,072
| -7% | -$84.1K | 0.15% | 119 |
|
|
2013
Q4 | $1.18M | Sell |
15,727
-50
| -0.3% | -$3.48K | 0.17% | 116 |
|
|
2013
Q3 | $992K | Buy |
15,777
+425
| +3% | +$25.4K | 0.15% | 119 |
|
|
2013
Q2 | $787K | Buy |
+15,352
| New | +$800K | 0.12% | 128 |
|
Other funds holding GILD
VCM
VPM
NBT Bank's GILD Position: Q1 2026 in Review
NBT Bank reduced its Gilead Sciences (GILD) stake by 0.56% in Q1 2026, selling an estimated $6.16K and leaving 7,879 shares worth $1.1M. The position accounts for 0.07% of the portfolio, ranked #200.
NBT Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.17M in Q3 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- NBT Bank held 7,879 shares of Gilead Sciences worth $1.1M as of Q1 2026.
- NBT Bank sold 44 Gilead Sciences shares in Q1 2026, an estimated $6.16K.
- Gilead Sciences made up 0.07% of NBT Bank's portfolio in Q1 2026, its #200 holding.
- NBT Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- NBT Bank's Gilead Sciences position peaked at $3.17M in Q3 2017.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.